HIV incidence among high-risk Puerto Rican drug users: A comparison of East Harlem, New York, and Bayamón, Puerto Rico

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 5, 2004, Pages 1067-1074

  Deren, Sherry ^a   Kang, Sung Yeon ^a   Colón, Hector M ^b   Andia, Jonny F ^a   Robles, Rafaela R ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Crack use; HIV incidence; HIV risk behaviors; Injection drug use; Puerto Rico

Indexed keywords

METHADONE;

ADULT; ARTICLE; CARIBBEAN ISLANDS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUERTO RICO; SEROCONVERSION; SEXUAL BEHAVIOR; SYRINGE; UNITED STATES; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HISPANIC AMERICANS; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; NEW YORK CITY; PUERTO RICO; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 3342963998     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200408150-00010     Document Type: Article

References (38)

1. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic. JAMA. 1994;27:121-127.
2. Robles RR, Colón HM, Matos TD, et al. Risk factors and HIV infection among three different cultural groups of injection drug users. In: Brown BS, Beschner GM, eds. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners. Westport, CT: Greenwood Press; 1993:256-274.
3. Andia JF, Deren S, Robles RR, et al. HIV-Related Risk Behaviors for Puerto Rican Drug Users in New York and Puerto Rico. Presented at the annual meeting of the American Public Health Association; Indianapolis, IN; 1997.
4. Matos TD, Robles RR, Marrero CA, et al. Crack Use in Puerto Rico: Evidence of a Recent Epidemic. Presented at the annual meeting of the American Public Health Association; San Francisco, CA; 1993.
5. Des Jarlais DC, Perlis TE, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health. 1998;88:1801-1806.
6. Des Jarlais DC. Trends in HIV Among IDUs in New York City. Presented at the 14th International AIDS Conference; Barcelona, Spain; 2002.
7. Friedman SR, Chapman TF, Perlis TE, et al. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. J Acquir Immune Defic Syndr. 1999;22:83-91.
8. Deren S, Robles RR, Andia JF, et al. Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. J Acquir Immune Defic Syndr. 2001;26:164-169.
9. Des Jarlais DC, Marmor M, Friedman P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352-359.
10. Holmberg S. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996;85:642-654.
11. Quan VM, Steketee RW, Valleroy L, et al. HIV incidence in the United States, 1978-1999. J Acquir Immune Defic Syndr. 2002;31:188-201.
12. Oliver-Velez D, Beardsley M, Deren S, et al. The Impact of Methadone Treatment on HIV Risk Behaviors Among Puerto Rican IDUs in East Harlem, New York and Bayamon, Puerto Rico. Presented at the annual meeting of the American Public Health Association; Chicago, IL; 1999.
13. Finlinson HA, Oliver-Vé;lez D, Colón HM, et al. Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: comparisons based on quantitative and qualitative methods. AIDS Behav. 2000;4:341-351.
14. Colón HM, Robles RR, Deren, et al. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamón, Puerto Rico. J Acquir Immune Defic Syndr. 2001; 27:405-413.
15. Deren S, Oliver-Velez D, Finlinson HA, et al. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Subst Use Misuse. 2003;38:1-24.
16. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
17. Rockwell R, Friedman SR, Sotheran JL, et al. Medical access for injecting drug users. In Singer M, ed. The Political Economy of AIDS. Amityville, NY: Baywood Press; 1998:131-147.
18. Des Jarlais DC, Friedman SR, Stoneburner R. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis. 1988;10:151-158.
19. Fennema JSA, van Ameijden EJC, Van Den Hoek A. et al. Young and recent onset injecting drag users are at higher risk for HIV. Addiction. 1997;92:1457-1465.
20. Koester S, Hoffer L. Indirect sharing: additional HIV risks associated with drug injection. AIDS Public Policy J. 1994;9;100-104.
21. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1:39-44.
22. Metzger DS, Navaline H, Woody GE Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113:97-106.
23. Normand J, Vlahov D, Moses L, eds. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.
24. Edlin BR, Irwin KL, Faruque S, et al. Intersecting epidemics-crack cocaine use and HIV infection among inner-city youth. N Engl J Med. 1994;331:1422-1427.
25. Elifson KW, Boles J, Darrow WW, et al. HIV seroprevalence and risk factors among clients of female and male prostitutes. J Acquir Immune Defic Syndr. 1999;20:195-200.
26. Friedman SR, Ompad DC, Maslow C, et al. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health. 2003;93:902-906.
27. Maslow C, Friedman SR, Perlis TE, et al. Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999. Am J Public Health. 2002;92:382-384.
28. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
29. Astemborsk J, Vlahov D, Warren D, et al. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health. 1994;84:382-387.
30. Oliver-Velez D, Finlinson HA, Deren S, et al. Mapping the air-bridge locations: the application of ethnographic mapping techniques to dual-site study of HIV risk behavior determinants in East Harlem, New York and Bayamón, Puerto Rico. Hum Org. 2002;61:262-276.
31. Deren S, Shedlin M, Hamilton T, et al. Impact of the September 11th attacks in New York City on drug users: a preliminary assessment. J Urban Health. 2002;79:409-412.
32. Colón HM. HIV Risks and Transitions to Injection among Non-IDUs [proposal]. Grant no. RO1DA015621, 2002. Funded by the National Institute on Drug Abuse.
33. Robles R, Mastro TD, Colón HM, et al. Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clin Infect Dis. 2003;37:S392-S403.
34. Hagan H, Thiede H, Weiss NS, et al. Sharing of drug preparation as a risk factor for hepatitis C. Am J Public Health. 2001;91:42-46.
35. Colón HM, Finlinson HA, Robles RR, et al. Joint drug purchases and drug preparation risk behaviors among injection drug users. AIDS Behav. 2001; 5:85-96.
36. National Institute on Health. Interventions to Prevent HIV Risk Behaviors: Consensus Statement. Bethesda, MD: NIH, Office of the Director; 1997:1-41.
37. National Institute on Drug Abuse. NIDA Community-Based Outreach Model: A Manual to Reduce the Risk of HIV and Other Blood-Borne Infections in Drug Users. Rockville, MD: National Institute on Drug Abuse, 2000.
38. United States Agency for International Development. Bush announces $15 billion AIDS relief plan. Frontlines. February 2003. Available at http://www.usaid.gov/pubs/frontlines/Feb03_FrontLines.pdf. Accessed June 18, 2003.